| Article ID | Journal | Published Year | Pages | File Type | 
|---|---|---|---|---|
| 5700855 | European Journal of Surgical Oncology (EJSO) | 2017 | 7 Pages | 
Abstract
												A prediction tool based on five parameters, including the biomarker S-100B, showed accurate risk stratification for NSN-involvement in SN-positive melanoma patients. If validated in future studies, this tool could help to identify patients with low risk for NSN-involvement.
											Related Topics
												
													Health Sciences
													Medicine and Dentistry
													Oncology
												
											Authors
												S. Damude, K.P. Wevers, R. Murali, S. Kruijff, H.J. Hoekstra, E. Bastiaannet, 
											